Navigation Links
Cell Culture Becomes an Integral Part of Cell Line Development and Engineering

LONDON, December 5, 2012 /PRNewswire/ --

- Market demands to reduce manufacturing costs require better Cell culture processes

According to further research conducted for the annual 2013 Cell Line Development & Engineering conference in Vienna next February, major developments in cell culture systems have given biotech's and pharmaceutical companies more flexibility to scale up cells to a high manufacturing quality. Cell engineering tools have enabled the production of high-performing cell lines and this has only been possible through improvements in cell culture media.

To best accommodate for these new developments, Informa Life Sciences' have expanded the programme to cover the latest in cell line development strategies and improvements in cell culture systems. Speaker Alison Porter, Head of Cell Line Development in the Mammalian Cell Culture group at Fujifilm Diosynth Biotechnologies (FFDB) clarifies how '‘With cell line construction on the critical path for first in human studies, it is vital to have optimised the early stages of cell line development. This can improve the future success of a biotherapeutic, both in terms of having the 'best' cell line and meeting increasingly tight timelines.'’

Further feedback from over 50 industry professionals and academics also highlight additional trends such as high throughput screening of cell lines, Quality by Design applications, cell line development strategies for novel products, analytical tools for product evaluation and bioinformatics applications.

Informa's annual 2013 Cell Line Development & Engineering conference has been designed to address topics essential to improve product development and quality. Susanna Benaim Conference Producer at Informa Life Sciences explains "The event uncovers the essentials in micro-scale system application, CHO genome sequencing, cell line engineering and targeted integration. The conference brings together leading experts from protein engineering, cell biology, cell line development and bioprocess, from both the pharmaceutical industry and academia. Any company specialising in this area is encouraged not to miss out."


Cell Line Development & Engineering 2013 will take place on the 11th-15th February 2013 at the NH Atlanta in Vienna, Austria. With a sold-out attendance in 2012 and a packed exhibition room, the 2013 conference is already receiving support from some of the leading names and companies in the industry including;

  • Dr Sanjeev Gupta (Intas Pharma)
  • Dr Otfried Kistner (Baxter Innovations)
  • Dr Baisong Mei (Biogen Idec)
  • Prof Dr Nicole Borth (BOKU)
  • Dr Eric Becker (Boehringer Ingelheim)
  • Prof Florian Wurum (ExcellGene)
  • Dr Alison Potter (Fuji Film)
  • Dr Marcos Arauzo-Bravo (Max Planck)
  • Dr Martin Jordan (Merck Serono)
  • Prof Alan Dickson (Uni. of Manchester)
  • Prof David James (Uni. Of Sheffield)
  • Prof Nicolas Mermod (Uni. Of Lausanne)

Delegates and exhibitors can apply by registering online. For more information on how to register or to download a copy of the programme, please visit

Other Related Events include;

Susanna Benaim
Conference Producer

James Miguel
Sales Director

SOURCE Informa Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Its Indiana State Fair Season: New BioCrossroads Report Emphasizes Opportunities in Food and Agriculture Innovation
2. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
3. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
4. Elsevier Launches New Journal: Learning, Culture and Social Interaction
5. Nano-pesticides: Solution or threat for a cleaner and greener agriculture?
6. Carbon nanotubes can double growth of cell cultures important in industry
7. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
8. Farm weeds have crucial role in sustainable agriculture
9. Mesenchymal Stem Cells Have New Cell Culture Environment
10. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
11. MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Natures Human Microbiota Special
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):